9-112804787-G-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001012994.2(SNX30):c.168G>T(p.Leu56Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000411 in 1,606,346 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001012994.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SNX30 | NM_001012994.2 | c.168G>T | p.Leu56Phe | missense_variant | 2/9 | ENST00000374232.8 | NP_001013012.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SNX30 | ENST00000374232.8 | c.168G>T | p.Leu56Phe | missense_variant | 2/9 | 5 | NM_001012994.2 | ENSP00000363349.3 |
Frequencies
GnomAD3 genomes AF: 0.000270 AC: 41AN: 151974Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000447 AC: 11AN: 246068Hom.: 0 AF XY: 0.00000749 AC XY: 1AN XY: 133558
GnomAD4 exome AF: 0.0000172 AC: 25AN: 1454372Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 723280
GnomAD4 genome AF: 0.000270 AC: 41AN: 151974Hom.: 0 Cov.: 32 AF XY: 0.000310 AC XY: 23AN XY: 74238
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2023 | The c.168G>T (p.L56F) alteration is located in exon 2 (coding exon 2) of the SNX30 gene. This alteration results from a G to T substitution at nucleotide position 168, causing the leucine (L) at amino acid position 56 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at